A lawsuit has been filed regarding the importation of foreign-market drugs, involving Gilead Sciences and Meritain Health, Inc.
3 reports, 1 independent
Updated Sep 11
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A lawsuit has been filed regarding the importation of foreign-market drugs, involving Gilead Sciences and Meritain Health, Inc.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- A U.S. patient case involving Gilead Sciences originated in Turkey, concerning revenue protection from generic imports.Sub-event
Lawsuit filed over importation of foreign-market drugs involving Gilead Sciences and Meritain Health, Inc.1 source
Keep exploring
The entities involved
-
Gilead Sciences
American company
- Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.
- A pilot program is underway involving the federal government, Benue State, and Gilead Sciences, with the state participating in the drug supply management.